James McCullough

Fondateur chez RENALYTIX PLC Fortune : 99 660 $ au 31/05/2026

Profil

James Renwick McCullough is the founder of Renalytix Plc, founded in 2018, where the title held is Chief Executive Officer & Director.
Mr. McCullough is also the founder of Paige.
AI, Inc...
Current jobs include Chairman at BalletNext, Inc., Director at The Bonnie J.
Addario Lung Cancer Foundation, Director at Kantaro Biosciences LLC, Director at Renalytix AI, Inc., and Director at Go2 Foundation For Lung Cancer.
Former jobs include Chief Executive Officer at Exosome Diagnostics, Inc. from 2008 to 2014, Director at Quentra Networks, Inc., Director at Ausam Biotechnologies, Inc., Director at TAVEC Pharmaceuticals, Non-Executive Director at Verici Dx Plc from 2020 to 2026, Independent Non-Executive Director at LungLife AI, Inc. from 2019 to 2024, and Managing Partner at Renwick Capital LLC from 2014 to 2021.
Education includes undergraduate studies at Boston University and an MBA from Columbia Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
RENALYTIX PLC 0,78%	12/02/2026	3 430 096 ( 0,78% )	83 214 $	31/05/2026
VERICI DX PLC 0,19%	31/12/2024	2 870 110 ( 0,19% )	16 446 $	31/05/2026

Postes actifs de James McCullough

Sociétés	Poste	Début
RENALYTIX PLC	Fondateur	15/03/2018
BalletNext, Inc.	Président	-
The Bonnie J. Addario Lung Cancer Foundation	Directeur/Membre du Conseil	-
Kantaro Biosciences LLC	Directeur/Membre du Conseil	-
Renalytix AI, Inc.	Directeur/Membre du Conseil	-
Go2 Foundation For Lung Cancer	Directeur/Membre du Conseil	-

Anciens postes connus de James McCullough

Sociétés	Poste	Fin
VERICI DX PLC	Directeur/Membre du Conseil	31/03/2026
LUNGLIFE AI, INC.	Directeur/Membre du Conseil	24/10/2024
Renwick Capital LLC	Corporate Officer/Principal	01/01/2021
░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-